141 related articles for article (PubMed ID: 7843264)
21. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Yu J; Källström L; Wiesel FA; Johnson AE
Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
[TBL] [Abstract][Full Text] [Related]
22. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.
Zink M; Schmitt A; May B; Müller B; Demirakca T; Braus DF; Henn FA
Schizophr Res; 2004 Feb; 66(2-3):151-7. PubMed ID: 15061247
[TBL] [Abstract][Full Text] [Related]
24. Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments.
Delfs JM; Anegawa NJ; Chesselet MF
Neuroscience; 1995 May; 66(1):67-80. PubMed ID: 7637876
[TBL] [Abstract][Full Text] [Related]
25. Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine.
Rupniak NM; Prestwich SA; Horton RW; Jenner P; Marsden CD
J Neural Transm; 1987; 68(1-2):113-25. PubMed ID: 3806083
[TBL] [Abstract][Full Text] [Related]
26. Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia.
Drew KL; O'Connor WT; Kehr J; Ungerstedt U
Eur J Pharmacol; 1990 Oct; 187(3):385-97. PubMed ID: 2073921
[TBL] [Abstract][Full Text] [Related]
27. Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain.
Collins CM; Wood MD; Elliott JM
J Psychopharmacol; 2014 Oct; 28(10):947-54. PubMed ID: 24989643
[TBL] [Abstract][Full Text] [Related]
28. Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.
See RE; Ellison G
Psychopharmacology (Berl); 1990; 100(3):404-12. PubMed ID: 2315437
[TBL] [Abstract][Full Text] [Related]
29. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
Abekawa T; Honda M; Ito K; Koyama T
Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
[TBL] [Abstract][Full Text] [Related]
30. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
Gao XM; Hashimoto T; Cooper TB; Tamminga CA
J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.
Spurney CF; Baca SM; Murray AM; Jaskiw GE; Kleinman JE; Hyde TM
Synapse; 1999 Dec; 34(4):266-76. PubMed ID: 10529721
[TBL] [Abstract][Full Text] [Related]
32. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
33. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
Meshul CK; Andreassen OA; Allen C; Jørgensen HA
Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
[TBL] [Abstract][Full Text] [Related]
34. The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex.
Chertkow Y; Weinreb O; Youdim MB; Silver H
Int J Neuropsychopharmacol; 2006 Jun; 9(3):287-96. PubMed ID: 15967061
[TBL] [Abstract][Full Text] [Related]
35. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
Osborne PG; O'Connor WT; Beck O; Ungerstedt U
Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
[TBL] [Abstract][Full Text] [Related]
36. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Collins-Praino LE; Podurgiel SJ; Kovner R; Randall PA; Salamone JD
Behav Brain Res; 2012 Sep; 234(1):129-35. PubMed ID: 22728308
[TBL] [Abstract][Full Text] [Related]
37. Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Rupniak NM; Briggs RS; Petersen MM; Mann S; Reavill C; Jenner P; Marsden CD
Clin Neuropharmacol; 1986; 9(3):282-92. PubMed ID: 3719573
[TBL] [Abstract][Full Text] [Related]
38. Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex.
See RE; Lynch AM
Neuroreport; 1995 Sep; 6(13):1795-8. PubMed ID: 8541484
[TBL] [Abstract][Full Text] [Related]
39. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
Gray AM; Connick JH
Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
[TBL] [Abstract][Full Text] [Related]
40. Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.
Egan MF; Karoum F; Wyatt RJ
Eur J Pharmacol; 1991 Jun; 199(2):191-9. PubMed ID: 1954977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
